Kiora Pharmaceuticals Q1 2026 Earnings EPS Beat Masks Continued PreRevenue Status as Stock Slips CW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency OPAL Fuels Q1 2026 Earnings EPS Miss Despite Operational Progress CEPU Q4 2024 Earnings Massive EPS Miss Amid Argentine Macro Headwinds IR Q1 2026 Earnings EPS Slightly Beats Estimates Stock Rises 214 PubMatic Q1 2026 Earnings EPS Surprises to the Upside Despite Challenging Ad Market